These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [What effect does losing weight have on hypertension?]. Engeli S MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188 [No Abstract] [Full Text] [Related]
47. Currently available drugs for the treatment of obesity: Sibutramine and orlistat. Chaput JP; St-Pierre S; Tremblay A Mini Rev Med Chem; 2007 Jan; 7(1):3-10. PubMed ID: 17266632 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. Viner RM; Hsia Y; Tomsic T; Wong IC Obes Rev; 2010 Aug; 11(8):593-602. PubMed ID: 19922432 [TBL] [Abstract][Full Text] [Related]
55. Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat. Davis RJ; Nomikos GG Mol Psychiatry; 2008 Mar; 13(3):240-1. PubMed ID: 18285757 [No Abstract] [Full Text] [Related]
56. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Coutinho W Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219 [TBL] [Abstract][Full Text] [Related]
57. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women. Sari R; Balci MK; Cakir M; Altunbas H; Karayalcin U Endocr Res; 2004 May; 30(2):159-67. PubMed ID: 15473126 [TBL] [Abstract][Full Text] [Related]
58. Pharmacologic treatment for obesity. Options for today...and tomorrow. Lundquist LM; Sirimaturos M; Cannon E Adv Nurse Pract; 2006 Aug; 14(8):31-5, 64. PubMed ID: 16972485 [No Abstract] [Full Text] [Related]
59. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review. Neovius M; Narbro K Int J Obes (Lond); 2008 Dec; 32(12):1752-63. PubMed ID: 18982009 [TBL] [Abstract][Full Text] [Related]